Table 2.
Caval-Aortic TAVR Details
| # | Sex | Reason for inoperability |
Best ilio- femora l MLD (mm) |
Sheath size (Fr) |
Crossing attempts (#) |
Crossing time (min) |
Closure device |
Device repositioned during closure |
Closure time (min) |
Hypotension during tract closure |
Angiographic pattern after closure |
Transfusion during TAVR |
CTRPH Score |
In- hospital complication |
Length of stay (days) |
Tract patency |
30-day MACE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | Prior SAVR & root repair; Failed prior TA-TAVR; eGFR<30; STS >10 |
4.8 | 22 | 3 | 75 | 12/10mm ADO |
— | 17 | — | 1 | — | 1 | T, V | 15 | O, day 44 |
None |
| 2 | F | Frailty; Immunocompromized |
5.1 | 24 | 1 | 23 | 10/8mm ADO |
— | 11 | — | 1 | + | 0 | — | 9 | P, day 36 |
R |
| 3 | F | Porcelain aorta; Failed SAVR; Immunocompromised |
6.5 | 22 | 3 | 67 | 8mm MVSDO |
+ | 48 | + | 2 | + | 2 | T, V | 11 | O, day 7 |
None |
| 4 | F | Severe COPD; Frailty |
6.6 | 24 | 3 | 17 | 10mm MVSDO |
— | 22 | — | 2 | — | 1 | — | 6 | O, day 189 |
None |
| 5 | F | Pulmonary artery hypertension Failed TF-TAVR |
7.4 | 22 | 3 | 17 | 8mm MVSDO |
— | 7 | — | 1 | — | 1 | T | 8 | O, day 42 |
R |
| 6 | M | Frailty; Prior CABG; Low EF |
4.9 | 24 | 2 | 16 | 10/8mm ADO |
— | 13 | + | 1 | + | — | Death | NA | NA | NA |
| 7 | F | Frailty; Prior CABG; |
6.7 | 22 | 3 | 75 | 6mm MVSDO |
— | 7 | — | 1 | — | 0 | T | 4 | O, day 36 |
None |
| 8 | M | Severe COPD | 4.5 | 24 | 1 | 28 | 8/6mm ADO |
— | 8 | — | 1 | — | 1 | — | 2 | O, day 86 |
None |
| 9 | F | Prior aortic root repair; Frailty; Failed TF-TAVR; STS >10 |
5.6 | 22 | 2 | 34 | 8mm MVSDO |
+ | 37 | + | 2 | + | 1 | T, V | 15 | O, day 15 |
None |
| 10 | F | COPD; porcelain aorta |
5.0 | 22 | 1 | 14 | 6mm MVSDO |
— | 8 | 2 | + | 0 | MI | 8 | O, day 8 |
None | |
| 11 | M | Low EF, prior CABG; eGFR<30; STS >10; |
6.0 | 24 | 1 | 14 | 8mm MVSDO |
+ | 21 | — | 2 | — | — | — | 8 | P, day 1 |
None |
| 12 | M | Frailty, prior CABG |
6.1 | 24 | 1 | 10 | 8mm MVSDO |
— | 18 | + | 2 | + | 2 | S, CIN | 34 | P, day 1 |
None |
| 13 | F | Age >90; Frailty; Porcelain aorta; STS >10 |
4.0 | 22 | 1 | 24 | 6mm MVSDO |
— | 3 | — | 2 | — | 0 | T | 8 | O, day 120 |
None |
| 14 | F | Low EF; Prior CABG; STS >10; |
7.6 | 24 | 1 | 14 | 8mm MVSDO |
+ | 15 | + | 3 | — | 1 | T, V | 13 | O, day 7 |
None |
| 15 | F | Age >90; Frailty; COPD; STS >10; |
5.6 | 22 | 1 | 20 | 6mm MVSDO |
— | 3 | — | 2 | + | — | — | 2 | O, day 9 |
None |
| 16 | F | COPD, Morbid obesity |
5.3 | 24 | 1 | 34 | 10/8mm ADO |
+ | 12 | — | 1 | — | 0 | T | 5 | O, day 56 |
None |
| 17 | F | Immunocompromised, porcelain aorta, religious beliefs |
5.0 | 22 | 1 | 30 | 6mm MVSDO |
— | 7 | — | 2 | — | 0 | V | 8 | O, day 54 |
None |
| 18 | F | Frailty, severe COPD |
5.0 | 24 | 1 | 15 | 8mm MVSDO |
— | 11 | — | 2 | — | 1 | T, V, GIB |
14 | O, day 57 |
None |
| 19 | F | Age, frailty, prior radiation/lymph node dissection |
6.5 | 24 | 1 | 10 | 8mm MVSDO |
— | 4 | — | 2 | — | 1 | T, GIB, CIN |
12 | O, day 36 |
None |
MLD=minimal luminal diameter; SAVR=surgical aortic valve replacement; TA-TAVR=transapical TAVR; eGFR=estimated glomerular filtration rate; STS=Society thoracic surgery predicted mortality score; COPD=chronic obstructive pulmonary disease; TF-=transfemoral; CABG=coronary artery bypass grafting; EF=ejection fraction; ADO=Amplatzer duct occluder; MVSDO= Amplatzer muscular ventricular septal defect occluder; RPH=Retroperitoneal hemorrhage; R=readmission; T=transfusion; V=vascular complication; MI=myocardial; infarction; S=Stroke; CIN=contrast induced nephropathy requiring hemodialysis; GIB=gastrointestinal bleed; P=patent; O=Occluded;.